| Items | Drug Registration information |
|---|---|
| ID | 1028 |
| No | 1028 |
| Brand Name | TUCAMAKS |
| Ingredients | TUCATINIB 150 MG |
| Dosage Form | TABLET |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 3 YEARS |
| Pack Size | 60 TABLETS/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | IN COMBINATION WITH TRASTUZUMAB AND CAPECITABINE FOR TREATMENT OF ADULT PATIENTS WITH ADVANCE UNRESECTABLE OR METASTATIC HER2-POSITIVE BREAST CANCER, INCLUDING PATIENT WITH BRAIN METASTASE WHO HAVE RECEIVED ONE OR MORE PRIOR ANTI-HER2-BASED REGIMENTS IN THE METASTATIC SETTING. |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | YELLOW BICONVEX FILM COATED TABLET |
| Note | |
| License Owner | FACTORY NO.2 |
| Manufacturer | FACTORY NO. 2 |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 04 L 1334/25 |
| FDD Registration Date | 07/04/2025 |
| Expiry Date | 06/04/2030 |